Diseases, Conditions, Syndromes

Study explains why myasthenia patients relapse after treatment

A new Yale-led study helps explain why some myasthenia gravis (MG) patients relapse after initially responding to a drug called rituximab, commonly used to treat the incurable autoimmune disease marked by muscle weakness ...

Psychology & Psychiatry

Experimental small molecule shows potential in preventing meth relapse

New research from The Scripps Research Institute (TSRI) suggests that the reason methamphetamine users find it so hard to quit—88 percent of them relapse, even after rehab—is that meth takes advantage of the brain's natural ...

page 13 from 30